Passage Bio
Founded in 2017, Passage Bio is a genetic medicines company based in Philadelphia, PA that is developing a portfolio of six life transforming AAV-delivered therapeutics for the treatment of rare monogenic central nervous system diseases.
Last updated on
About Passage Bio
Founded
2018Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$442MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
28NAICs Code
325414Location
City
PhiladelphiaState
PennsylvaniaCountry
United StatesTech Stack (42)
